Pharmacyclics, Inc. (NASDAQ:PCYC)
CAPS Rating:
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.
Growing the love for investing
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
This is a great stock... To short. Pump and dump; today is 01/8/10 and they've been enjoying a 105% rally for the past month
Boy, you really nailed this one. let's see, it is now $5.69 and you were saying???? You guys are too funny.
Excuse me whilst I don my oxygen mask for the high altitude ahead
Odds for volitility are too high in pharm. Either you lose big or win big. I'm unlucky so go long on the ones I thumb down...
You're almost the biggest loser on this one. Perhaps you should read up what the docs are saying about the trials. Oh, and in this wonderful age of computers, you can read what the patients are saying about their own trial experiences with PCI-32765 - good news spreading like wildfire. 70% objective response rates and only tested in refractory patients - yeah, that's a real crap shoot.
THe most exciting news has not even come yet - they will be starting anti-inflammatory trials in 2012 (arthritis) - same drug.
THe term blockbuster has already been assigned to this - by doctors no less!
Good luck, and gods speed.